Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

Phase 4 Recruiting 350 enrolled Mayo Clinic Eurofins · collab Transplant Genomics, Inc. · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research is to determine the safety and efficacy of withdrawing MMF (Mycophenolate Mofetil) in kidney transplant recipients who are 55 years or older at the time of receiving a kidney transplant. We are comparing them to patients who receive the standard of care Mycophenolate Mofetil.

Timeline

Start: 2025-06-13
Primary completion: 2030-12-31
Completion: 2031-03-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Mycophenolate Mofetil	Small molecule	—	Oral

Indications

No indication recorded.